Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes
Part of paid clinical trials in Beverly Hills, California.
- Sponsor
- Aclarion
- Study ID
- NCT06661850
- Status
- Recruiting
Conditions
- Discogenic Low Back Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Fusion or TDR determined by investigator. — PROCEDUREThe surgical treatment will be decided by the treating investigator based on their clinical judgement.
Study Details
This study is looking into how safe and useful NOCISCAN is. NOCISCAN is a software as a Service (SaaS) tool that uses Magnetic Resonance (MR) spectroscopy. Nociscan (instead of 'It') leverages MRS to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. The randomized controlled trial will compare the blinded and unblinded cohorts and their corresponding surgical outcomes with the Nocigram reports, generated prior to treatment, for each patient."
Key Dates
- Start date
- Jun 11, 2025
- Status verified
- May 2026
- Primary completion
- Sep 30, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Blinded-to-NOCISCANNOCISCAN completed pre-operatively. Investigator will not have access to NOCISCAN result.
- Arm: Unblinded-to-NOCISCANNOCISCAN completed pre-operatively. Investigator will have access to the NOCISCAN result after completing initial treatment plan but before treatment.
Primary Outcome Measure
Change in back pain on 100mm Visual Analog Scale (VAS) Pain Assessment [ Time Frame: Baseline to 12 months ]
Central Contacts
- Ryan Bond724-991-3369
- Andy Murillo
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Todd H. Lanman, M.D Inc | Beverly Hills | California | 90210 | Todd Lanman, MD (PRINCIPAL_INVESTIGATOR) |
| Scripps Health | La Jolla | California | 92037 | Hani Malone, MD (PRINCIPAL_INVESTIGATOR) |
| USC Keck Medical Center | Los Angeles | California | 90033 | Patrick Hsieh, MD (PRINCIPAL_INVESTIGATOR) |
| University of Miami/ Jackson Health System | Miami | Florida | 33136 | Gregory Basil, MD (PRINCIPAL_INVESTIGATOR) |
| Northwestern University | Chicago | Illinois | 60611 | Alpesh Patel, MD (PRINCIPAL_INVESTIGATOR) |
| Advocate Aurora Research Institute | Park Ridge | Illinois | 60068 | Patrick Sugrue, MD (PRINCIPAL_INVESTIGATOR) |
| Johns Hopkins Medicine | Baltimore | Maryland | 21287 | Daniel Lubelski, MD (PRINCIPAL_INVESTIGATOR) |
| Texas Back Institute | Plano | Texas | 75093 | Alexander Satin, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Beverly Hills, CA
Related Studies
- PerQdisc Traditional Feasibility Trial.Recruiting · Spinal Stabilization Technologies · Glendale, Arizona